Wobenzyme, 40 pcs.

Wobenzyme is a combination of natural enzymes of plant and animal origin. Entering the body, enzymes are absorbed in the small intestine by resorption of intact molecules and, binding with blood transport proteins, enter the bloodstream. Further enzymes migrating through the vascular bed and accumulating in the area of pathological process have immunomodulatory, anti-inflammatory, fibrinolytic, anti-edema, anti-aggregant and secondary-analgesic effect.

Wobenzyme has a positive effect on the inflammatory process, limits the pathological manifestations of autoimmune and immunocomplex processes, has a positive effect on the immunological reactivity. It stimulates and regulates the level of functional activity of monocytes-macrophages, natural killer cells, stimulates antitumor immunity, cytotoxic T-lymphocytes, phagocytic cell activity.

Wobenzym reduces the number of circulating immune complexes and removes membrane deposits of immune complexes from tissues.

Wobenzym reduces infiltration of interstitium by plasma cells. Increases elimination of protein detritus and fibrin deposits in the inflammation zone, accelerates lysis of toxic products of metabolism and necrotized tissues. Wobenzyme normalizes vascular permeability and contributes to a more rapid resolution of hematomas and edemas.

Wobenzyme reduces thromboxane concentration and platelet aggregation. It regulates blood cell adhesion, increases the ability of red blood cells to change their shape by regulating their plasticity, normalizes the number of normal disco-cytes and reduces the total number of activated forms of platelets, normalizes blood viscosity, reduces the total number of micro-aggregates, thereby improving microcirculation and blood rheology, and tissue supply with oxygen and nutrients.

Wobenzyme reduces the severity of side effects associated with taking hormones (hypercoagulation and others).

Wobenzyme normalizes lipid metabolism, reduces the synthesis of endogenous cholesterol, increases high density lipoproteins, reduces atherogenic lipids, improves the absorption of polyunsaturated fatty acids.

Wobenzyme increases the concentration of antibiotics in blood plasma and in the center of inflammation, thus increasing their effectiveness. At the same time enzymes reduce unwanted side effects of antibiotic therapy (disbacteriosis) by improving the environment.

Wobenzyme regulates non-specific defense mechanisms (production of interferons), thereby showing antiviral and antimicrobial action.

Indications

It is used in complex therapy of the following diseases:

Angiology: thrombophlebitis, treatment of postthrombophlebitis disease and acute thrombophlebitis of superficial veins, endarteritis and obliterating atherosclerosis of the arteries of the lower extremities, prevention of recurrent phlebitis, lymphedema.

Urology: cystitis, cystopyelitis, prostatitis, sexually transmitted infections.

Gynecology: chronic genital infections, adnexitis, gestosis, mastopathy, to reduce the frequency and severity of side effects of hormone replacement therapy.

Cardiology: angina pectoris, subacute stage of myocardial infarction (to improve the rheological properties of blood).

Pulmonology: sinusitis, bronchitis, pneumonia.

Gastroenterology: pancreatitis, hepatitis.

Nephrology: pyelonephritis, glomerulonephritis.

Endocrinology: diabetic angiopathy, diabetic retinopathy, autoimmune thyroiditis.

Rheumatology: rheumatoid arthritis, reactive arthritis, ankylosing spondylitis.

Dermatology: atopic dermatitis, acne.

Surgery: prevention and treatment of postoperative complications (inflammation, thrombosis, edema), adhesive disease, post-traumatic and lymphatic edema, plastic and reconstructive surgeries.

Traumatology: injuries, fractures, distortions, ligamentous injuries, bruises, chronic post-traumatic processes, inflammation of soft tissues, burns, injuries in sports medicine.

Neurology: multiple sclerosis.

Pediatrics: atopic dermatitis, infectious and inflammatory diseases of the respiratory tract (inflammation of the upper and lower respiratory tract, pneumonia), juvenile rheumatoid arthritis, prevention and treatment of postoperative complications (suppuration and poor wound healing, formation of adhesions, local edema).

Ophthalmology: Uveitis, iridocyclitis, hemophthalmos, diabetic retinopathy, ophthalmic surgery.

Wobenzym is recommended for the prevention of infectious complications and improvement of quality of life during chemotherapy or radiation therapy. Prevention of the development of viral infections and their complications.

Pharmacological effect

Pharmacological effect
WOBENZYM is a combination of natural enzymes of plant and animal origin. Entering the body, enzymes are absorbed in the small intestine by resorption of intact molecules and, by binding to transport proteins in the blood, enter the bloodstream. Subsequently, enzymes, migrating along the vascular bed and accumulating in the area of ​​the pathological process, have an immunomodulatory, anti-inflammatory, fibrinolytic, decongestant, antiplatelet and secondary analgesic effect. WOBENZYM has a positive effect on the course of the inflammatory process, limits the pathological manifestations of autoimmune and immune complex processes, and has a positive effect on the body’s immunological reactivity. Stimulates and regulates the level of functional activity of monocytes-macrophages, natural killer cells, stimulates antitumor immunity, cytotoxic T-lymphocytes, and phagocytic activity of cells. Under the influence of WOBENZYME, the number of circulating immune complexes decreases and membrane deposits of immune complexes are removed from tissues. WOBENZYME reduces the infiltration of the interstitium by plasma cells. Increases the elimination of protein debris and fibrin deposits in the area of ​​inflammation, accelerates the lysis of toxic metabolic products and necrotic tissue. WOBENZYM normalizes the permeability of vessel walls, promotes faster resorption of hematomas and edema. WOBENZYME reduces the concentration of thromboxane and platelet aggregation. Regulates the adhesion of blood cells, increases the ability of red blood cells to change their shape, regulating their plasticity, normalizes the number of normal discocytes and reduces the total number of activated forms of platelets, normalizes blood viscosity, reduces the total number of microaggregates, thus improving microcirculation and rheological properties of blood, as well as the supply of tissues with oxygen and nutrients. WOBENZYME reduces the severity of side effects associated with taking hormonal drugs (hypercoagulation, etc.). WOBENZYM normalizes lipid metabolism, reduces the synthesis of endogenous cholesterol, increases the content of high-density lipoproteins, reduces the level of atherogenic lipids, and improves the absorption of polyunsaturated fatty acids. WOBENZYM increases the concentration of antibiotics in the blood plasma and the site of inflammation, thus increasing the effectiveness of their use. At the same time, enzymes reduce the unwanted side effects of antibiotic therapy (dysbacteriosis), by improving the environment. WOBENZYME regulates nonspecific defense mechanisms (production of interferons), thereby exhibiting antiviral and antimicrobial effects.

Special instructions

In the case of infectious processes, WOBENZYM does not replace antibiotics, but increases their effectiveness by increasing the concentration in the blood plasma and the site of inflammation. It should be borne in mind that at the very beginning of taking the drug, the symptoms of the disease may worsen; in such cases, treatment should not be interrupted, but a temporary reduction in the dose of the drug is recommended. The drug is not a dope.

Active ingredient

Trypsin, Pancreatin, Rutoside, Chymotrypsin, Bromelain, Lipase, Amylase, Papain

Composition

Active ingredients
Pancreatin + Papain + Rutoside trihydrate + Bromelain + Trypsin + Lipase + Amylase + Chymotrypsin

1 enteric film-coated tablet contains:
Core: Active ingredients: Pancreatin 300 Prot. Unit (100.0 mg), papain 90 FIP Units. (18.00 mg), rutoside trihydrate 50.00 mg, bromelain 225 FIP Units. (45.00 mg), trypsin 360 FIP Units. (12.00 mg), lipase 34 FIP Units. (10.00 mg), amylase 50 FIP Units. (10.00 mg), chymotrypsin 300 FIP Units. (0.75 mg).
Excipients: Lactose monohydrate 149 mg, pregelatinized starch 31.3 mg, magnesium stearate 6.00 mg, stearic acid 6.00 mg, colloidal anhydrous silicon dioxide 3.00 mg, talc 1.50 mg.
Shell: Film coating 11.9 mg (methacrylic acid-methyl methacrylate copolymer (1:1) 11.9 mg, sodium lauryl sulfate 0.04 mg), talc 4.23 mg, macrogol 6000 0.67 mg, triethyl citrate 1.20 mg, stearic acid 6.00 mg, color coating 12.8 mg (hypromellose 3.20 mg, hydroxypropylcellulose 3.83 mg, microcrystalline cellulose 1.60 mg, glycerol 0.64 mg, talc 1.92 mg, titanium dioxide 0.38 mg, crimson dye 4R (E 124) 0.38 mg, yellow-orange dye S (E 110) 0.83 mg).

Pregnancy

Pregnancy and breastfeeding are not a contraindication for the use of the drug, however, pregnant women should take WOBENZYM under the supervision of a physician.

Contraindications

• individual hypersensitivity to the components of the drug,
• severe congenital or acquired bleeding disorders (hemophilia, severe liver damage),
• diseases associated with an increased likelihood of bleeding,
• thrombocytopenia.

Side Effects

• nausea,
• slight changes in the consistency and smell of stool,
• allergic reaction
• anaphylactic reactions,
• vomiting,
• temporary feeling of fullness in the stomach,
• flatulence,
• diarrhea,
• erythema,
• itching,
• hyperhidrosis.

Interaction

When Wobenzym is taken simultaneously with other medications, cases of incompatibility have not been described.

Overdose

There are no known cases of drug overdose.

Storage conditions

At a temperature not exceeding 25 °C. Keep out of the reach of children!

Shelf life

2 years. Do not use after expiration date.

Manufacturer

Mucos Pharma, Germany